TY - JOUR
T1 - Comparative Growth Outcomes in Preterm Infants Fed Either Mother's Own Milk or Donor Human Milk
AU - Velumula, Pradeep Kumar
AU - Elbakoush, Faesal
AU - Elfadeel, Hiba
AU - Lulic-Botica, Mirjana
AU - Natarajan, Girija
AU - Bajaj, Monika
N1 - Publisher Copyright:
© 2023 Mary Ann Liebert, Inc., publishers.
PY - 2023/4/1
Y1 - 2023/4/1
N2 - Objective: To compare growth velocity (GV) in preterm infants fed mother's own milk (MOM) fortified with human milk-based fortifier (HMBF) to those who received donor human milk (DHM) fortified with HMBF. Study Design: A retrospective study of preterm infants with birth weight <1,250 g receiving an exclusive human milk diet. Maternal and infant charts were reviewed for feeding, growth, and short-term neonatal morbidities. Results: On regression analysis, after adjusting (gestational age, multiple births, antenatal steroids, and small for gestational age), no significant difference was observed between the two groups in GV from birth to 32 weeks postmenstrual age (β-coefficient 0.83, 95% confidence interval [CI]: -0.47 to 2.14, p = 0.21), GV from the day of regaining of birth weight to discharge (β-coefficient -0.015, 95% CI: -1.08 to 1.05, p = 0.98). The rate of Grade 3 and 4 intraventricular hemorrhage was significantly higher in the DHM group (19.6% compared to 5.5% in MOM, p = 0.03). Conclusion: At our institution, there was no difference in GV of preterm infants fed HMBF-fortified MOM versus HMBF-fortified DBM.
AB - Objective: To compare growth velocity (GV) in preterm infants fed mother's own milk (MOM) fortified with human milk-based fortifier (HMBF) to those who received donor human milk (DHM) fortified with HMBF. Study Design: A retrospective study of preterm infants with birth weight <1,250 g receiving an exclusive human milk diet. Maternal and infant charts were reviewed for feeding, growth, and short-term neonatal morbidities. Results: On regression analysis, after adjusting (gestational age, multiple births, antenatal steroids, and small for gestational age), no significant difference was observed between the two groups in GV from birth to 32 weeks postmenstrual age (β-coefficient 0.83, 95% confidence interval [CI]: -0.47 to 2.14, p = 0.21), GV from the day of regaining of birth weight to discharge (β-coefficient -0.015, 95% CI: -1.08 to 1.05, p = 0.98). The rate of Grade 3 and 4 intraventricular hemorrhage was significantly higher in the DHM group (19.6% compared to 5.5% in MOM, p = 0.03). Conclusion: At our institution, there was no difference in GV of preterm infants fed HMBF-fortified MOM versus HMBF-fortified DBM.
KW - donor human milk
KW - growth velocity
KW - mother's own milk
KW - preterm infants
KW - short-term neonatal outcomes
UR - http://www.scopus.com/inward/record.url?scp=85152977067&partnerID=8YFLogxK
U2 - 10.1089/bfm.2022.0224
DO - 10.1089/bfm.2022.0224
M3 - Article
C2 - 36971613
AN - SCOPUS:85152977067
SN - 1556-8253
VL - 18
SP - 300
EP - 306
JO - Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine
JF - Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine
IS - 4
ER -